-
Something wrong with this record ?
How to: Clostridioides difficile infection in children
M. Krutova, TGJ. de Meij, F. Fitzpatrick, RJ. Drew, MH. Wilcox, EJ. Kuijper
Language English Country England, Great Britain
Document type Journal Article, Review
- MeSH
- Anti-Bacterial Agents therapeutic use MeSH
- Clostridioides difficile * MeSH
- Child MeSH
- Fidaxomicin therapeutic use MeSH
- Clostridium Infections * diagnosis epidemiology therapy MeSH
- Humans MeSH
- Aged MeSH
- Vancomycin therapeutic use MeSH
- Check Tag
- Child MeSH
- Humans MeSH
- Aged MeSH
- Publication type
- Journal Article MeSH
- Review MeSH
BACKGROUND: Clostridioides difficile infections (CDI) are traditionally attributed to an older adult patient group but children can also be affected. Although the causative pathogen is the same in both populations, the management of CDI may differ. OBJECTIVES: To discuss the current literature on CDI in the paediatric population and to provide CDI diagnostics and treatment guidance. SOURCES: The literature was drawn from a search of PubMed from January 2017 to July 2021. CONTENT: In the paediatric population, laboratory diagnostics for CDI should preferably be combined with laboratory diagnostics for other gastrointestinal pathogens. Coinfections of CDI are also possible. Though the detection of toxigenic C. difficile using a molecular assay may simply reflect colonisation rather than infection, detection of C. difficile free toxins A/B in faeces is much more indicative of true infection. CDI in children below 2 years of age and in the absence of risk factors is very difficult to diagnose and requires careful clinical judgement pending additional studies. Fidaxomicin has been shown to be superior to vancomycin with a sustained clinical response up to 30 days after the end of CDI treatment in children. Metronidazole is less effective than vancomycin in adults and there are no supporting data for its use in children. In recurrent CDI, treatment should be adjusted according to the drug or drug regimen used for the treatment of a previous episode(s). In multiple recurrent CDI, faecal microbiota transplantation can be effective. IMPLICATIONS: If CDI laboratory testing is indicated in children with diarrhoea, the likelihood of C. difficile colonisation and coinfection with other intestinal pathogens should be considered. The currently available data support a change in the treatment strategy of CDI in children.
European Society of Clinical Microbiology and Infectious Diseases
European Society of Clinical Microbiology and Infectious Diseases Basel Switzerland
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc22024990
- 003
- CZ-PrNML
- 005
- 20221031100210.0
- 007
- ta
- 008
- 221017s2022 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.cmi.2022.03.001 $2 doi
- 035 __
- $a (PubMed)35283312
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Krutova, Marcela $u Department of Medical Microbiology, 2nd Faculty of Medicine, Charles University, Motol University Hospital, Prague, Czech Republic; European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Study Group for Clostridioides difficile (ESGCD), Basel, Switzerland; European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Study Group for Host and Microbiota Interaction (ESGHAMI). Electronic address: marcela.krutova@lfmotol.cuni.cz
- 245 10
- $a How to: Clostridioides difficile infection in children / $c M. Krutova, TGJ. de Meij, F. Fitzpatrick, RJ. Drew, MH. Wilcox, EJ. Kuijper
- 520 9_
- $a BACKGROUND: Clostridioides difficile infections (CDI) are traditionally attributed to an older adult patient group but children can also be affected. Although the causative pathogen is the same in both populations, the management of CDI may differ. OBJECTIVES: To discuss the current literature on CDI in the paediatric population and to provide CDI diagnostics and treatment guidance. SOURCES: The literature was drawn from a search of PubMed from January 2017 to July 2021. CONTENT: In the paediatric population, laboratory diagnostics for CDI should preferably be combined with laboratory diagnostics for other gastrointestinal pathogens. Coinfections of CDI are also possible. Though the detection of toxigenic C. difficile using a molecular assay may simply reflect colonisation rather than infection, detection of C. difficile free toxins A/B in faeces is much more indicative of true infection. CDI in children below 2 years of age and in the absence of risk factors is very difficult to diagnose and requires careful clinical judgement pending additional studies. Fidaxomicin has been shown to be superior to vancomycin with a sustained clinical response up to 30 days after the end of CDI treatment in children. Metronidazole is less effective than vancomycin in adults and there are no supporting data for its use in children. In recurrent CDI, treatment should be adjusted according to the drug or drug regimen used for the treatment of a previous episode(s). In multiple recurrent CDI, faecal microbiota transplantation can be effective. IMPLICATIONS: If CDI laboratory testing is indicated in children with diarrhoea, the likelihood of C. difficile colonisation and coinfection with other intestinal pathogens should be considered. The currently available data support a change in the treatment strategy of CDI in children.
- 650 _2
- $a senioři $7 D000368
- 650 _2
- $a antibakteriální látky $x terapeutické užití $7 D000900
- 650 _2
- $a dítě $7 D002648
- 650 12
- $a Clostridioides difficile $7 D016360
- 650 12
- $a klostridiové infekce $x diagnóza $x epidemiologie $x terapie $7 D003015
- 650 _2
- $a fidaxomicin $x terapeutické užití $7 D000077732
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a vankomycin $x terapeutické užití $7 D014640
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a přehledy $7 D016454
- 700 1_
- $a de Meij, Tim G J $u Department of Paediatric Gastroenterology, Emma Children's Hospital, Amsterdam UMC, University of Amsterdam, the Netherlands
- 700 1_
- $a Fitzpatrick, Fidelma $u Department of Clinical Microbiology, Royal College of Surgeons in Ireland and Beaumont Hospital, Dublin, Ireland; European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Study Group for Clostridioides difficile (ESGCD), Basel, Switzerland; European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Study Group for Host and Microbiota Interaction (ESGHAMI)
- 700 1_
- $a Drew, Richard J $u Irish Meningitis and Sepsis Reference Laboratory, Children's Health Ireland at Temple Street, Dublin, Ireland; European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Study Group for Clostridioides difficile (ESGCD), Basel, Switzerland
- 700 1_
- $a Wilcox, Mark H $u Healthcare Associated Infection Research Group, Leeds Teaching Hospitals NHS Trust & University of Leeds, Leeds, United Kingdom; European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Study Group for Clostridioides difficile (ESGCD), Basel, Switzerland
- 700 1_
- $a Kuijper, Ed J $u Department of Medical Microbiology and National Reference Laboratory for CDI, Leiden University Medical Centre and National Institute for Public Health and the Environment, Leiden, Netherlands; European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Study Group for Clostridioides difficile (ESGCD), Basel, Switzerland; European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Study Group for Host and Microbiota Interaction (ESGHAMI)
- 773 0_
- $w MED00001139 $t Clinical microbiology and infection $x 1469-0691 $g Roč. 28, č. 8 (2022), s. 1085-1090
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/35283312 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20221017 $b ABA008
- 991 __
- $a 20221031100208 $b ABA008
- 999 __
- $a ok $b bmc $g 1854605 $s 1176280
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2022 $b 28 $c 8 $d 1085-1090 $e 20220310 $i 1469-0691 $m Clinical microbiology and infection $n Clin Microbiol Infect $x MED00001139
- LZP __
- $a Pubmed-20221017